ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,120Medicare Part D Prescriptions Filled, Including Refills

Rank: 400 out of 1677

$441K Total Retail Price of All Prescriptions

Rank: 439 out of 1677

317 Patients Receiving at Least One Drug in Part D
72%Patients 65 Years and Older
78% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Georgia
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 317 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

27% of this provider’s 317 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

2% of this provider’s 6,607 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$48 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

29 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Georgia
SIMVASTATIN 420 304 1 1
OMEPRAZOLE 418 306 2 6
HYDROCODONE-ACETAMINOPHEN 358 236 S3 3 4
LISINOPRIL 345 250 4 3
AMLODIPINE BESYLATE 291 232 5 2
METOPROLOL TARTRATE 270 187 6 12
FUROSEMIDE 239 194 7 8
CITALOPRAM HBR 226 152 8 22
LEVOTHYROXINE SODIUM 194 136 9 5
METFORMIN HCL 188 149 10 7
TRAMADOL HCL 163 111 11 16
HYDROCHLOROTHIAZIDE 156 106 12 9
CARVEDILOL 140 119 13 20
ZOLPIDEM TARTRATE 124 86 14 15
NEXIUM 112 55 15 19
WARFARIN SODIUM 106 83 16 24
CYCLOBENZAPRINE HCL 96 56 R 17 52
DONEPEZIL HCL 96 84 17 30
SERTRALINE HCL 95 62 19 26
RANITIDINE HCL 92 45 20 18
GABAPENTIN 90 62 21 11
CLOPIDOGREL 83 56 22 32
POTASSIUM CHLORIDE 77 54 23 14
PROMETHAZINE HCL 76 32 R 24 64
ATORVASTATIN CALCIUM 72 62 25 13
BUSPIRONE HCL 72 55 25 120
LANTUS 69 31 27 44
NAMENDA 67 67 28 39
PLAVIX 67 51 28 47
ATENOLOL 67 45 28 21
MELOXICAM 65 42 31 27
ADVAIR DISKUS 65 56 31 54
DIGOXIN 63 62 33 71
AZITHROMYCIN 63 52 33 38
JANUVIA 60 37 35 70
TAMSULOSIN HCL 57 54 36 34
LOSARTAN POTASSIUM 56 37 37 25
SPIRIVA 55 45 38 74
FLUOXETINE HCL 53 30 39 49
RISPERIDONE 53 53 39 60
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 11, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.